TENAX THERAPEUTICS INC's ticker is and the CUSIP is 88032L209. A total of 26 filers reported holding TENAX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $17,707 | – | 160,968 | +946770.6% | 0.00% | – |
| Q3 2022 | $0 | – | 17 | -29.2% | 0.00% | – |
| Q2 2022 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 24 | -99.5% | 0.00% | – |
| Q4 2021 | $5,000 | – | 4,811 | +11634.1% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 41 | -95.8% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 980 | +17.1% | 0.00% | – |
| Q1 2021 | $2,000 | -88.2% | 837 | -90.9% | 0.00% | – |
| Q4 2020 | $17,000 | – | 9,154 | +12793.0% | 0.00% | – |
| Q3 2020 | $0 | – | 71 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 71 | -95.2% | 0.00% | – |
| Q1 2020 | $1,000 | – | 1,488 | +1966.7% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 72 | -99.2% | 0.00% | – |
| Q3 2019 | $11,000 | +450.0% | 9,161 | +505.5% | 0.00% | – |
| Q2 2019 | $2,000 | -83.3% | 1,513 | -74.0% | 0.00% | – |
| Q1 2019 | $12,000 | +20.0% | 5,817 | -26.5% | 0.00% | – |
| Q4 2018 | $10,000 | -16.7% | 7,915 | +246.1% | 0.00% | – |
| Q3 2018 | $12,000 | -36.8% | 2,287 | -23.4% | 0.00% | – |
| Q2 2018 | $19,000 | +72.7% | 2,984 | +50.9% | 0.00% | – |
| Q1 2018 | $11,000 | – | 1,978 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 43,164 | $61,000 | 0.02% |
| FAS Wealth Partners, Inc. | 58,576 | $83,000 | 0.01% |
| Gradient Investments LLC | 1 | $0 | 0.00% |
| Hudock, Inc. | 1 | $0 | 0.00% |
| Allworth Financial LP | 1 | $0 | 0.00% |
| VANGUARD GROUP INC | 12,200 | $17,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 5,018 | $7,000 | 0.00% |
| UBS Group AG | 72 | $0 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| Advisor Group, Inc. | 3,065 | $4,000 | 0.00% |